<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.0.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>primary pulmonary hypertension</title>
	<link>http://www.your-news-blog.com/primary-pulmonary-hypertension</link>
	<description>Just another WordPress weblog</description>
	<pubDate>Thu, 07 Aug 2008 13:32:43 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.0.2</generator>
	<language>en</language>
			<item>
		<title>Exercise-induced pulmonary hypertension common in systemic sclerosis - Medicexchange  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/07/exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis-medicexchange-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/07/exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis-medicexchange-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Thu, 07 Aug 2008 13:32:43 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/07/exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis-medicexchange-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[




Exercise-induced pulmonary hypertension  common in systemic sclerosisMedicexchange,&#160;UK&#160;- 2 hours agoPulmonary arterial hypertension (PAH) can often become apparent during exercise testing in patients with systemic sclerosis, according to a report in the &#8230;



 Read More&#8230;


dBTechno


Uninsured And Chronically ill: The New American Health RiskThe Money Times,&#160;India&#160;- Aug 5, 2008&#8230; ambit of the study include cardiovascular disease, [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.medicexchange.com/news.aspx/14779/Exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNEEv9suOt8Cs-r1qmtdawhLQUcxcg">Exercise-induced <b>pulmonary hypertension</b>  common in systemic sclerosis</a><br /><font size=-1><font color=#6f6f6f>Medicexchange,&nbsp;UK&nbsp;-</font> <nobr>2 hours ago</nobr></font><br /><font size=-1><b>Pulmonary</b> arterial <b>hypertension</b> (PAH) can often become apparent during exercise testing in patients with systemic sclerosis, according to a report in the <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.medicexchange.com/news.aspx/14779/Exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNEEv9suOt8Cs-r1qmtdawhLQUcxcg'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td width=80 align=center valign=top><font style="font-size:85%;font-family:arial,sans-serif"><a target="_blank" rel="nofollow"  href="http://news.google.com/news/url?sa=T&#038;ct=us/4i-0&#038;fd=R&#038;url=http://www.dbtechno.com/health/2008/08/05/one-third-of-uninsured-americans-suffering-from-chronic-illness/&#038;cid=1233455387&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNEB30SwmJ9yXHDHabh0fGP8u4NdfQ"><img src=http://news.google.com/news?imgefp=-p_CRJ1XDwwJ&#038;imgurl=www.dbtechno.com/images/uninsured_americans_chronic_illness.jpg width=80 height=52 alt="" border=1><br /><font size=-2>dBTechno</font></a></font></td>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/4-0&#038;fd=R&#038;url=http://www.themoneytimes.com/articles/20080805/uninsured_and_chronically_ill_the_new_american_health_risk-id-1031675.html&#038;cid=1233455387&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNHtbuY2NtJ9ccdVsbKCXBE5fHJv0w">Uninsured And Chronically ill: The New American Health Risk</a><br /><font size=-1><font color=#6f6f6f>The Money Times,&nbsp;India&nbsp;-</font> <nobr>Aug 5, 2008</nobr></font><br /><font size=-1><b>&#8230;</b> ambit of the study include cardiovascular disease, <b>hypertension</b>, diabetes, asthma, high cholesterol, chronic obstructive <b>pulmonary</b> disease and cancer. <b>&#8230;</b></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/4-1&#038;fd=R&#038;url=http://health.usnews.com/articles/health/healthday/2008/08/04/one-third-of-uninsured-are-chronically-ill.html&#038;cid=1233455387&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNEGCWxClk3JvTObRMT5He3L2ZWyag">One-Third of Uninsured Are Chronically Ill</a> <font size=-1 color=#6f6f6f><nobr>U.S. News &#038; World Report</nobr></font></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/4-2&#038;fd=R&#038;url=http://www.mcknights.com/Chronic-conditions-afflict-millions-of-uninsured-adults/article/113435/&#038;cid=1233455387&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNErFA7_2iAaLhRTJzUEE3Lyi48ejQ">Chronic conditions afflict millions of uninsured adults</a> <font size=-1 color=#6f6f6f><nobr>McKnight&#8217;s Long Term Care News</nobr></font></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news?btcid=a746e2379fa7a6e0"><img src="/images/news_comment_bubble12.gif" alt="google news comment" class="comment-icon">Comment by&nbsp;Karen Davis, Ph.D.</a><font size=-1 color=#6f6f6f>&nbsp;President, The Commonwealth Fund</font></font><br /><font class=p size=-1><a target="_blank" rel="nofollow" class=p href=http://news.google.com/news?hl=en&#038;ned=us&#038;ie=ISO-8859-1&#038;ncl=1233455387><nobr>all 39 news articles</nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/4-0&#038;fd=R&#038;url=http://www.themoneytimes.com/articles/20080805/uninsured_and_chronically_ill_the_new_american_health_risk-id-1031675.html&#038;cid=1233455387&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNHtbuY2NtJ9ccdVsbKCXBE5fHJv0w'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/7-0&#038;fd=R&#038;url=http://www.gulfbreezenews.com/news/2008/0807/Faith/030.html&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNGkrKYGqeBAkZXp2f2FvHJSXibfeA">2008 Leadership Summit under way at GBUMC</a><br /><font size=-1><font color=#6f6f6f>Gulf Breeze News,&nbsp; USA&nbsp;-</font> <nobr>17 hours ago</nobr></font><br /><font size=-1>In 2004, Thompson was diagnosed with Lupus and severe <b>pulmonary hypertension</b> that is stressing her lungs, liver and heart. Lupus is an autoimmune disease <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/7-0&#038;fd=R&#038;url=http://www.gulfbreezenews.com/news/2008/0807/Faith/030.html&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNGkrKYGqeBAkZXp2f2FvHJSXibfeA'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.marketwatch.com/news/story/epix-pharmaceuticals-secures-committed-equity/story.aspx%3Fguid%3D%257B7E9FD211-C146-49B0-82B4-FA8DD4957FDF%257D%26dist%3Dhppr&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNFYYqlnpigzY1DpmfRayRNg-9nQsQ">EPIX Pharmaceuticals Secures Committed Equity Financing Facility</a><br /><font size=-1><font color=#6f6f6f>MarketWatch&nbsp;-</font> <nobr>Aug 5, 2008</nobr></font><br /><font size=-1><b>&#8230;</b> expect to commence our Phase 2b trial for PRX-08066 for the treatment of <b>pulmonary hypertension</b> associated with chronic obstructive <b>pulmonary</b> disease. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.marketwatch.com/news/story/epix-pharmaceuticals-secures-committed-equity/story.aspx?guid=%7B7E9FD211-C146-49B0-82B4-FA8DD4957FDF%7D&#038;dist=hppr&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNFYYqlnpigzY1DpmfRayRNg-9nQsQ'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/2-0&#038;fd=R&#038;url=http://www.forbes.com/business/2008/08/06/pharmaceuticals-fda-biz-healthcare-cx_mh_0807fda.html&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNHoUOKF_e3kIw1V-RRsrQuFQcC0kQ">The FDA&#39;s Black Box</a><br /><font size=-1><font color=#6f6f6f>Forbes,&nbsp;NY&nbsp;-</font> <nobr>3 hours ago</nobr></font><br /><font size=-1><b>&#8230;</b> three &quot;approvable&quot; letters from the FDA requesting more study on a drug to treat a rare disease called <b>pulmonary hypertension</b>, the last in 2007. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/2-0&#038;fd=R&#038;url=http://www.forbes.com/business/2008/08/06/pharmaceuticals-fda-biz-healthcare-cx_mh_0807fda.html&#038;cid=0&#038;ei=ffmaSObMHoHI8ASbqMznBA&#038;usg=AFQjCNHoUOKF_e3kIw1V-RRsrQuFQcC0kQ'>Read More&#8230;</a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/07/exercise-induced-pulmonary-hypertension-common-in-systemic-sclerosis-medicexchange-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>EU Extends Indication of Bosentan to Pulmonary Arterial &#8230; - DG News  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news-2/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news-2/#comments</comments>
		<pubDate>Thu, 07 Aug 2008 02:30:43 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news-2/</guid>
		<description><![CDATA[




EU Extends Indication of Bosentan to Pulmonary Arterial &#8230;DG News&#160;- 10 hours ago&#8230; for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH World Health Organization [WHO] functional class [FC] II). &#8230;



 Read More&#8230;




WKU To Induct Three Into Hall Of Distinguished AlumniAmplifier,&#160;KY&#160;- 3 hours ago&#8230; Sharron H. Francisfrancis for her role in research [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.docguide.com/news/content.nsf/news/852571020057CCF68525749D0052CC2B&#038;cid=0&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNEg3pirIAeQsy27-O39DmtJ4RdUqg">EU Extends Indication of Bosentan to <b>Pulmonary</b> Arterial <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>DG News&nbsp;-</font> <nobr>10 hours ago</nobr></font><br /><font size=-1><b>&#8230;</b> for the treatment of patients with mildly symptomatic <b>pulmonary</b> arterial <b>hypertension</b> (PAH World Health Organization [WHO] functional class [FC] II). <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.docguide.com/news/content.nsf/news/852571020057CCF68525749D0052CC2B&#038;cid=0&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNEg3pirIAeQsy27-O39DmtJ4RdUqg'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://www.bgdailynews.com/articles/2008/08/06/the_amplifier/community/9859wkuinductees.txt&#038;cid=0&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNGCKWBKbL_AoSEqJDL3K9S5KF9dng">WKU To Induct Three Into Hall Of Distinguished Alumni</a><br /><font size=-1><font color=#6f6f6f>Amplifier,&nbsp;KY&nbsp;-</font> <nobr>3 hours ago</nobr></font><br /><font size=-1><b>&#8230;</b> Sharron H. Francisfrancis for her role in research that led to development of drugs to treat erectile dysfunction and <b>pulmonary</b> arterial <b>hypertension</b>. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://www.bgdailynews.com/articles/2008/08/06/the_amplifier/community/9859wkuinductees.txt&#038;cid=0&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNGCKWBKbL_AoSEqJDL3K9S5KF9dng'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/4-0&#038;fd=R&#038;url=http://www.genengnews.com/news/bnitem.aspx%3Fname%3D39891020&#038;cid=1233791844&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNGb2YB_zWcZQhaN8mA6_OIb0Zpklg">Vivus Pockets $65M and Kingsbridge Proffers $60M to Acadia as well <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Genetic Engineering News (press release),&nbsp;NY&nbsp;-</font> <nobr>Aug 5, 2008</nobr></font><br /><font size=-1><b>&#8230;</b> expect to commence our Phase 2b trial for PRX-08066 for the treatment of <b>pulmonary hypertension</b> associated with chronic obstructive <b>pulmonary</b> disease.”</font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/4-0&#038;fd=R&#038;url=http://www.genengnews.com/news/bnitem.aspx?name=39891020&#038;cid=1233791844&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNGb2YB_zWcZQhaN8mA6_OIb0Zpklg'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td width=80 align=center valign=top><font style="font-size:85%;font-family:arial,sans-serif"><a target="_blank" rel="nofollow"  href="http://news.google.com/news/url?sa=T&#038;ct=us/5i-0&#038;fd=R&#038;url=http://www.dbtechno.com/health/2008/08/05/one-third-of-uninsured-americans-suffering-from-chronic-illness/&#038;cid=1233455387&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNFJRvnIhipBnvytuXajxh-t5xVfPA"><img src=http://news.google.com/news?imgefp=-p_CRJ1XDwwJ&#038;imgurl=www.dbtechno.com/images/uninsured_americans_chronic_illness.jpg width=80 height=52 alt="" border=1><br /><font size=-2>dBTechno</font></a></font></td>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.themoneytimes.com/articles/20080805/uninsured_and_chronically_ill_the_new_american_health_risk-id-1031675.html&#038;cid=1233455387&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNFDCb3Yp4TFz39m3cWeDL4zoyp57Q">Uninsured And Chronically ill: The New American Health Risk</a><br /><font size=-1><font color=#6f6f6f>The Money Times,&nbsp;India&nbsp;-</font> <nobr>Aug 5, 2008</nobr></font><br /><font size=-1><b>&#8230;</b> ambit of the study include cardiovascular disease, <b>hypertension</b>, diabetes, asthma, high cholesterol, chronic obstructive <b>pulmonary</b> disease and cancer. <b>&#8230;</b></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-1&#038;fd=R&#038;url=http://health.usnews.com/articles/health/healthday/2008/08/04/one-third-of-uninsured-are-chronically-ill.html&#038;cid=1233455387&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNF_VnL6TNiDC1EcQiv-o0uUf8pafA">One-Third of Uninsured Are Chronically Ill</a> <font size=-1 color=#6f6f6f><nobr>U.S. News &#038; World Report</nobr></font></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-2&#038;fd=R&#038;url=http://www.mcknights.com/Chronic-conditions-afflict-millions-of-uninsured-adults/article/113435/&#038;cid=1233455387&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNF8g4ck0eeVm8sbJehM72VMcPXdig">Chronic conditions afflict millions of uninsured adults</a> <font size=-1 color=#6f6f6f><nobr>McKnight&#8217;s Long Term Care News</nobr></font></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news?btcid=a746e2379fa7a6e0"><img src="/images/news_comment_bubble12.gif" alt="google news comment" class="comment-icon">Comment by&nbsp;Karen Davis, Ph.D.</a><font size=-1 color=#6f6f6f>&nbsp;President, The Commonwealth Fund</font></font><br /><font class=p size=-1><a target="_blank" rel="nofollow" class=p href=http://news.google.com/news?hl=en&#038;ned=us&#038;ie=ISO-8859-1&#038;ncl=1233455387><nobr>all 39 news articles</nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.themoneytimes.com/articles/20080805/uninsured_and_chronically_ill_the_new_american_health_risk-id-1031675.html&#038;cid=1233455387&#038;ei=Vl6aSLS5OIHI8ATOqPTnBA&#038;usg=AFQjCNFDCb3Yp4TFz39m3cWeDL4zoyp57Q'>Read More&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news-2/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>EU Extends Indication of Bosentan to Pulmonary Arterial &#8230; - DG News  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Thu, 07 Aug 2008 02:30:06 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[




EU Extends Indication of Bosentan to Pulmonary Arterial &#8230;DG News&#160;- 10 hours ago&#8230; for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH World Health Organization [WHO] functional class [FC] II). &#8230;



 Read More&#8230;




Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary &#8230;Medscape (subscription)&#160;- Jul 31, 2008Pulmonary arterial hypertension (PAH) is characterized by  progressive [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/2-0&#038;fd=R&#038;url=http://www.docguide.com/news/content.nsf/news/852571020057CCF68525749D0052CC2B&#038;cid=0&#038;ei=MV6aSOiuH5LgyQS3hIjnBA&#038;usg=AFQjCNGpKIcc0Zkw7wk7XpTg89SE-JKW3A">EU Extends Indication of Bosentan to <b>Pulmonary</b> Arterial <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>DG News&nbsp;-</font> <nobr>10 hours ago</nobr></font><br /><font size=-1><b>&#8230;</b> for the treatment of patients with mildly symptomatic <b>pulmonary</b> arterial <b>hypertension</b> (PAH World Health Organization [WHO] functional class [FC] II). <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/2-0&#038;fd=R&#038;url=http://www.docguide.com/news/content.nsf/news/852571020057CCF68525749D0052CC2B&#038;cid=0&#038;ei=MV6aSOiuH5LgyQS3hIjnBA&#038;usg=AFQjCNGpKIcc0Zkw7wk7XpTg89SE-JKW3A'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/9-0&#038;fd=R&#038;url=http://www.medscape.com/viewarticle/577964&#038;cid=0&#038;ei=MV6aSOiuH5LgyQS3hIjnBA&#038;usg=AFQjCNEGm0xVWN_XVN82pgy4ho2KssETbA">Endothelin Antagonist Trial in Mildly Symptomatic <b>Pulmonary</b> <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Medscape (subscription)&nbsp;-</font> <nobr>Jul 31, 2008</nobr></font><br /><font size=-1><b>Pulmonary</b> arterial <b>hypertension</b> (PAH) is characterized by  progressive <b>pulmonary</b> arterial vasoconstriction and remodeling, leading to a marked rise in <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/9-0&#038;fd=R&#038;url=http://www.medscape.com/viewarticle/577964&#038;cid=0&#038;ei=MV6aSOiuH5LgyQS3hIjnBA&#038;usg=AFQjCNEGm0xVWN_XVN82pgy4ho2KssETbA'>Read More&#8230;</a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/06/eu-extends-indication-of-bosentan-to-pulmonary-arterial-dg-news-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>One-Third of Uninsured Are Chronically Ill - U.S. News &#038; World Report  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/05/one-third-of-uninsured-are-chronically-ill-us-news-world-report-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/05/one-third-of-uninsured-are-chronically-ill-us-news-world-report-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Tue, 05 Aug 2008 13:31:33 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/05/one-third-of-uninsured-are-chronically-ill-us-news-world-report-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[




One-Third of Uninsured Are Chronically IllU.S. News &#038; World Report,&#160;DC&#160;- 16 hours agoOther conditions examined were asthma, high cholesterol, chronic obstructive pulmonary disease or a previous diagnosis of cancer. &#8230;



 Read More&#8230;




Sleep wellSouthtown Star,&#160;IL&#160;- 4 hours agoNow Sahloul is trying to help people rest easy at the new Southwest Sleep Center and Pulmonary Consultants in [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/4-0&#038;fd=R&#038;url=http://health.usnews.com/articles/health/healthday/2008/08/04/one-third-of-uninsured-are-chronically-ill.html&#038;cid=1233455387&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNF7NIe7jWBlJNAu_6r3MpJYwjsE-w">One-Third of Uninsured Are Chronically Ill</a><br /><font size=-1><font color=#6f6f6f>U.S. News &#038; World Report,&nbsp;DC&nbsp;-</font> <nobr>16 hours ago</nobr></font><br /><font size=-1>Other conditions examined were asthma, high cholesterol, chronic obstructive <b>pulmonary</b> disease or a previous diagnosis of cancer. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/4-0&#038;fd=R&#038;url=http://health.usnews.com/articles/health/healthday/2008/08/04/one-third-of-uninsured-are-chronically-ill.html&#038;cid=1233455387&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNF7NIe7jWBlJNAu_6r3MpJYwjsE-w'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://www.southtownstar.com/lifestyles/1090115,080508wellnesswatch.article&#038;cid=0&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNGkx21B6GguDfriG_YmRpt4j0q5Og">Sleep well</a><br /><font size=-1><font color=#6f6f6f>Southtown Star,&nbsp;IL&nbsp;-</font> <nobr>4 hours ago</nobr></font><br /><font size=-1>Now Sahloul is trying to help people rest easy at the new Southwest Sleep Center and <b>Pulmonary</b> Consultants in Oak Lawn. According to Sahloul, a sleep <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://www.southtownstar.com/lifestyles/1090115,080508wellnesswatch.article&#038;cid=0&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNGkx21B6GguDfriG_YmRpt4j0q5Og'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.foxbusiness.com/story/markets/industries/health-care/tracleerr-bosentan-receives-eu-approval-treatment-patients-mildly-symptomatic/&#038;cid=0&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNHIQYdBKah25M67XnZa2QKQfq4nqQ">Tracleer(R) (bosentan) receives EU approval for treatment of <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>FOXBusiness&nbsp;-</font> <nobr>23 hours ago</nobr></font><br /><font size=-1>Survival in patients with <b>primary pulmonary hypertension</b>: Results from a national prospective registry. Ann Intern Med 1991;115:343-349. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.foxbusiness.com/story/markets/industries/health-care/tracleerr-bosentan-receives-eu-approval-treatment-patients-mildly-symptomatic/&#038;cid=0&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNHIQYdBKah25M67XnZa2QKQfq4nqQ'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.medicalnewstoday.com/articles/117083.php&#038;cid=0&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNEHNto0dtULHPMcW6mpq2JTG37oqQ">Tracleer(R) (bosentan) Receives EU Approval For Treatment Of <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Medical News Today (press release),&nbsp;UK&nbsp;-</font> <nobr>Aug 4, 2008</nobr></font><br /><font size=-1>The <b>primary</b> endpoints for the EARLY trial were  changes in <b>pulmonary</b> vascular resistance (PVR) and exercise capacity as measured by a 6-minute walk test <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.medicalnewstoday.com/articles/117083.php&#038;cid=0&#038;ei=NVaYSO7OIZ_I8ATy8rXeBA&#038;usg=AFQjCNEHNto0dtULHPMcW6mpq2JTG37oqQ'>Read More&#8230;</a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/05/one-third-of-uninsured-are-chronically-ill-us-news-world-report-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Tracleer(R) (bosentan) Receives EU Approval For Treatment Of &#8230; - Medical News Today (press release)  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/04/tracleerr-bosentan-receives-eu-approval-for-treatment-of-medical-news-today-press-release-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/04/tracleerr-bosentan-receives-eu-approval-for-treatment-of-medical-news-today-press-release-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Tue, 05 Aug 2008 00:30:51 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/04/tracleerr-bosentan-receives-eu-approval-for-treatment-of-medical-news-today-press-release-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[




Tracleer(R) (bosentan) Receives EU Approval For Treatment Of &#8230;Medical News Today (press release),&#160;UK&#160;- 15 hours agoThe primary endpoints for the EARLY trial were  changes in pulmonary vascular resistance (PVR) and exercise capacity as measured by a 6-minute walk test &#8230;Tracleer® (bosentan) receives EU approval for treatment of &#8230; Ad-Hoc-News (Pressemitteilung)all 8 news articles



 Read [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.medicalnewstoday.com/articles/117083.php&#038;cid=1233428527&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNF-u3e6oQNfekkbSl5_agDbEeJ4tQ">Tracleer(R) (bosentan) Receives EU Approval For Treatment Of <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Medical News Today (press release),&nbsp;UK&nbsp;-</font> <nobr>15 hours ago</nobr></font><br /><font size=-1>The <b>primary</b> endpoints for the EARLY trial were  changes in <b>pulmonary</b> vascular resistance (PVR) and exercise capacity as measured by a 6-minute walk test <b>&#8230;</b></font><br /><font size=-1><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-1&#038;fd=R&#038;url=http://www.ad-hoc-news.de/Handelssignale/18723025/Tracleer%25AE%2B(bosentan)%2Breceives%2BEU%2Bapproval%2Bfor%2Btreatment%2Bof%2Bpatients%2Bwith%2Bmildly%2Bsymptomatic%2BPulmonary%2BArterial%2BHypertension&#038;cid=1233428527&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNGU6XNsPSQtGz7O1Gxlmn2DpZ93Gw">Tracleer® (bosentan) receives EU approval for treatment of <b>&#8230;</b></a> <font size=-1 color=#6f6f6f><nobr>Ad-Hoc-News (Pressemitteilung)</nobr></font></font><br /><font class=p size=-1><a target="_blank" rel="nofollow" class=p href=http://news.google.com/news?hl=en&#038;ned=us&#038;ie=ISO-8859-1&#038;ncl=1233428527><nobr>all 8 news articles</nobr></a></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.medicalnewstoday.com/articles/117083.php&#038;cid=1233428527&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNF-u3e6oQNfekkbSl5_agDbEeJ4tQ'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/7-0&#038;fd=R&#038;url=http://www.star-telegram.com/health/story/807245.html&#038;cid=1232956740&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNGO-J5SXK2Xd69dMLrl2wTswl1B4g">Health Happenings</a><br /><font size=-1><font color=#6f6f6f>Fort Worth Star Telegram,&nbsp;TX&nbsp;-</font> <nobr>4 hours ago</nobr></font><br /><font size=-1>COPD (chronic obstructive <b>pulmonary</b> disease) Support Group, for <b>pulmonary</b> patients and their families, meets at 1:30 pm the first Tuesday of the month at <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/7-0&#038;fd=R&#038;url=http://www.star-telegram.com/health/story/807245.html&#038;cid=1232956740&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNGO-J5SXK2Xd69dMLrl2wTswl1B4g'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/3-0&#038;fd=R&#038;url=http://www.annals.org/cgi/content/abstract/149/3/170&#038;cid=0&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNEbJcnhRkzqXQc3wHUu_JTRQRk8Ig">A National Study of Chronic Disease Prevalence and Access to Care <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Annals of Internal Medicine&nbsp;-</font> <nobr>2 hours ago</nobr></font><br /><font size=-1><b>&#8230;</b> <b>hypertension</b>, diabetes, hypercholesterolemia, active asthma or chronic obstructive <b>pulmonary</b> disease, previous cancer, and measures of access to care. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/3-0&#038;fd=R&#038;url=http://www.annals.org/cgi/content/abstract/149/3/170&#038;cid=0&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNEbJcnhRkzqXQc3wHUu_JTRQRk8Ig'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://health.usnews.com/articles/health/healthday/2008/08/04/one-third-of-uninsured-are-chronically-ill.html&#038;cid=1233455387&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNHYiqPMaHnh0PLNw8ihkR0Dlj3noQ">One-Third of Uninsured Are Chronically Ill</a><br /><font size=-1><font color=#6f6f6f>U.S. News &#038; World Report,&nbsp;DC&nbsp;-</font> <nobr>3 hours ago</nobr></font><br /><font size=-1>Other conditions examined were asthma, high cholesterol, chronic obstructive <b>pulmonary</b> disease or a previous diagnosis of cancer. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://health.usnews.com/articles/health/healthday/2008/08/04/one-third-of-uninsured-are-chronically-ill.html&#038;cid=1233455387&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNHYiqPMaHnh0PLNw8ihkR0Dlj3noQ'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.tmcnet.com/usubmit/-planned-rd-hike-gives-gilead-investors-pause-/2008/08/04/3583811.htm&#038;cid=0&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNGwJyizn4q2uVAUC3Udf0lTqo5R6w">Planned R&amp;D Hike Gives Gilead Investors Pause</a><br /><font size=-1><font color=#6f6f6f>TMCnet&nbsp;-</font> <nobr>1 hour ago</nobr></font><br /><font size=-1>The company also is pushing forward with cicletanine, a once-daily oral agent in <b>pulmonary</b> arterial <b>hypertension</b> (PAH) and recently started a Phase IV trial <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.tmcnet.com/usubmit/-planned-rd-hike-gives-gilead-investors-pause-/2008/08/04/3583811.htm&#038;cid=0&#038;ei=Pp-XSO_5OorI8AS6jOTdBA&#038;usg=AFQjCNGwJyizn4q2uVAUC3Udf0lTqo5R6w'>Read More&#8230;</a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/04/tracleerr-bosentan-receives-eu-approval-for-treatment-of-medical-news-today-press-release-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Edmond teen fights back - Edmond Sun  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/edmond-teen-fights-back-edmond-sun-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/edmond-teen-fights-back-edmond-sun-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Sun, 03 Aug 2008 22:30:44 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/edmond-teen-fights-back-edmond-sun-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[




Edmond teen fights backEdmond Sun,&#160;OK&#160;- Aug 1, 2008EDMOND — Lauren Johnson, 16, looks like a normal teenager on the outside but daily fights the symptoms of a disease called pulmonary hypertension, &#8230;



 Read More&#8230;




Lung transplant recipient recoveringDubuque Telegraph Herald,&#160;IA&#160;- Jul 31, 2008Tuesday&#39;s procedure was Nick&#39;s second transplant. A rare lung ailment called primary pulmonary hypertension [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/2-0&#038;fd=R&#038;url=http://www.edmondsun.com/homepage/local_story_214230612.html%3Fkeyword%3Dleadpicturestory&#038;cid=0&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNE8U-A8m4nYv81OJoADBEFpLtv34g">Edmond teen fights back</a><br /><font size=-1><font color=#6f6f6f>Edmond Sun,&nbsp;OK&nbsp;-</font> <nobr>Aug 1, 2008</nobr></font><br /><font size=-1>EDMOND — Lauren Johnson, 16, looks like a normal teenager on the outside but daily fights the symptoms of a disease called <b>pulmonary hypertension</b>, <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/2-0&#038;fd=R&#038;url=http://www.edmondsun.com/homepage/local_story_214230612.html?keyword=leadpicturestory&#038;cid=0&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNE8U-A8m4nYv81OJoADBEFpLtv34g'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.thonline.com/article.cfm%3Fid%3D210684&#038;cid=0&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNG0kd_lMS8TGEjigUDEHfFyzvMCUg">Lung transplant recipient recovering</a><br /><font size=-1><font color=#6f6f6f>Dubuque Telegraph Herald,&nbsp;IA&nbsp;-</font> <nobr>Jul 31, 2008</nobr></font><br /><font size=-1>Tuesday&#39;s procedure was Nick&#39;s second transplant. A rare lung ailment called <b>primary pulmonary hypertension</b> led to his first transplant a decade ago.</font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.thonline.com/article.cfm?id=210684&#038;cid=0&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNG0kd_lMS8TGEjigUDEHfFyzvMCUg'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.medscape.com/viewarticle/577964&#038;cid=0&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNFjpFqvx5A8hnp1fHtsTez-xtdiZQ">Endothelin Antagonist Trial in Mildly Symptomatic <b>Pulmonary</b> <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Medscape (subscription)&nbsp;-</font> <nobr>Jul 31, 2008</nobr></font><br /><font size=-1><b>Pulmonary</b> arterial <b>hypertension</b> (PAH) is characterized by  progressive <b>pulmonary</b> arterial vasoconstriction and remodeling, leading to a marked rise in <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/0-0&#038;fd=R&#038;url=http://www.medscape.com/viewarticle/577964&#038;cid=0&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNFjpFqvx5A8hnp1fHtsTez-xtdiZQ'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://www.thonline.com/article.cfm%3Fid%3D210591&#038;cid=1232168808&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNFmydX-kLWozuCNxRki_bVtwQ3bow">Dubuque boy undergoes transplant</a><br /><font size=-1><font color=#6f6f6f>Dubuque Telegraph Herald,&nbsp;IA&nbsp;-</font> <nobr>Jul 30, 2008</nobr></font><br /><font size=-1>A rare lung ailment called <b>primary pulmonary hypertension</b> led to his first transplant a decade ago. Doctors had hoped the first transplanted lungs would <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/1-0&#038;fd=R&#038;url=http://www.thonline.com/article.cfm?id=210591&#038;cid=1232168808&#038;ei=lzGWSKbJGIK6ywSe_sjaBA&#038;usg=AFQjCNFmydX-kLWozuCNxRki_bVtwQ3bow'>Read More&#8230;</a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/edmond-teen-fights-back-edmond-sun-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Support Groups - Eagle Tribune  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/support-groups-eagle-tribune-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/support-groups-eagle-tribune-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Sun, 03 Aug 2008 05:30:43 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/support-groups-eagle-tribune-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[




Support GroupsEagle Tribune,&#160;MA&#160;- 1 hour agoAnyone interested in learning more about scleroderma and pulmonary hypertension is welcome. For more information, call Pat Gelinas at 329-8382 or the &#8230;



 Read More&#8230;




First half 2008 financial results: NicOx nears completion of phase &#8230;FOXBusiness&#160;- Jul 28, 2008The two studies have recruited a total of 417 osteoarthritis patients with controlled [...]]]></description>
			<content:encoded><![CDATA[<p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/3-0&#038;fd=R&#038;url=http://www.eagletribune.com/punews/local_story_215234316.html&#038;cid=1232907787&#038;ei=h0KVSNDeE4LM8AT72rTZBA&#038;usg=AFQjCNHhTHZP54b9O-YHxEuJORnRW3AKvA">Support Groups</a><br /><font size=-1><font color=#6f6f6f>Eagle Tribune,&nbsp;MA&nbsp;-</font> <nobr>1 hour ago</nobr></font><br /><font size=-1>Anyone interested in learning more about scleroderma and <b>pulmonary hypertension</b> is welcome. For more information, call Pat Gelinas at 329-8382 or the <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/3-0&#038;fd=R&#038;url=http://www.eagletribune.com/punews/local_story_215234316.html&#038;cid=1232907787&#038;ei=h0KVSNDeE4LM8AT72rTZBA&#038;usg=AFQjCNHhTHZP54b9O-YHxEuJORnRW3AKvA'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/6-0&#038;fd=R&#038;url=http://www.foxbusiness.com/story/markets/industries/health-care/half--financial-results-nicox-nears-completion-phase--naproxcinod-studies/&#038;cid=1230811840&#038;ei=h0KVSNDeE4LM8AT72rTZBA&#038;usg=AFQjCNFrOalHtTr8zoaO2TzK7bKuZor-Ug">First half 2008 financial results: NicOx nears completion of phase <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>FOXBusiness&nbsp;-</font> <nobr>Jul 28, 2008</nobr></font><br /><font size=-1>The two studies have recruited a total of 417 osteoarthritis patients with controlled <b>hypertension</b> and results are projected in the fourth quarter of 2008. <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/6-0&#038;fd=R&#038;url=http://www.foxbusiness.com/story/markets/industries/health-care/half--financial-results-nicox-nears-completion-phase--naproxcinod-studies/&#038;cid=1230811840&#038;ei=h0KVSNDeE4LM8AT72rTZBA&#038;usg=AFQjCNFrOalHtTr8zoaO2TzK7bKuZor-Ug'>Read More&#8230;</a></p>
<table border=0 width= valign=top cellpadding=2 cellspacing=7>
<tr>
<td valign=top class=j><font style="font-size:85%;font-family:arial,sans-serif"><br />
<div style="padding-top:0.8em;"><img alt="" height="1" width="1"></div>
<div class=lh><a target="_blank" rel="nofollow" href="http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.medicalnewstoday.com/articles/117013.php&#038;cid=0&#038;ei=h0KVSNDeE4LM8AT72rTZBA&#038;usg=AFQjCNGAax9Fgfe7j5BDws8Ezrn4m5fGIg">HomeCARE II: BIOTRONIK Launches Clinical Study Using Inovative <b>&#8230;</b></a><br /><font size=-1><font color=#6f6f6f>Medical News Today (press release),&nbsp;UK&nbsp;-</font> <nobr>16 hours ago</nobr></font><br /><font size=-1>Many heart failure patients have <b>pulmonary</b> congestion. The new sensor technology will continuously monitor lung fluid levels (intrathoracic impedance) in <b>&#8230;</b></font></div>
<p></font></td>
</tr>
</table>
<p> <a target="_blank" rel="nofollow" href='http://news.google.com/news/url?sa=T&#038;ct=us/5-0&#038;fd=R&#038;url=http://www.medicalnewstoday.com/articles/117013.php&#038;cid=0&#038;ei=h0KVSNDeE4LM8AT72rTZBA&#038;usg=AFQjCNGAax9Fgfe7j5BDws8Ezrn4m5fGIg'>Read More&#8230;</a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/03/support-groups-eagle-tribune-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>New Eloxatin(R) and Taxotere(R) Data in Several Tumor Types to Be - PR Newswire  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/02/new-eloxatinr-and-taxoterer-data-in-several-tumor-types-to-be-pr-newswire-primary-pulmonary-hypertension-news-7/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/02/new-eloxatinr-and-taxoterer-data-in-several-tumor-types-to-be-pr-newswire-primary-pulmonary-hypertension-news-7/#comments</comments>
		<pubDate>Sat, 02 Aug 2008 11:30:41 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/02/new-eloxatinr-and-taxoterer-data-in-several-tumor-types-to-be-pr-newswire-primary-pulmonary-hypertension-news-7/</guid>
		<description><![CDATA[- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting&#8217;s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ &#8212; Sanofi-aventis U.S. announced today that key study results from the company&#8217;s    Read More 
Background: In 1999, the country began a political, legal, economical and social transition process with the objective [...]]]></description>
			<content:encoded><![CDATA[<p>- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting&#8217;s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ &#8212; Sanofi-aventis U.S. announced today that key study results from the company&#8217;s    <a target="_blank" rel="nofollow" href='http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&#038;STORY=/www/story/05-31-2006/0004371644&#038;EDATE='>Read More </a></p>
<p>Background: In 1999, the country began a political, legal, economical and social transition process with the objective to initiate a new development model that strengthens the democratic system. The political transition has allowed the writing of the    <a target="_blank" rel="nofollow" href='http://www.paho.org/English/DD/AIS/cp_862.htm'>Read More </a></p>
<p>Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary arterial vasoconstriction and remodeling, leading to a marked rise in pulmonary vascular resistance (PVR), pulmonary hypertension, right ventricular dysfunction    <a target="_blank" rel="nofollow" href='http://www.medscape.com/viewarticle/577964'>Read More </a></p>
<p>Physicians face a daunting task in achieving and maintaining competence in drug therapy. Essential underpinnings of rational drug therapy that are taught in medical school, including physiology, pharmacokinetics, and pharmacodynamics, are all too    <a target="_blank" rel="nofollow" href='http://www.medscape.com/viewarticle/543641_3'>Read More </a></p>
<p>IRVINE, Calif., Feb. 20 /PRNewswire/ &#8212; LifeMasters Supported SelfCare, Inc., a national provider of health improvement services, announced that it has received an extension from the Centers for Medicare &#038; Medicaid Services (CMS) of its disease    <a target="_blank" rel="nofollow" href='http://sev.prnewswire.com/health-care-hospitals/20080220/LAW05120022008-1.html'>Read More </a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/08/02/new-eloxatinr-and-taxoterer-data-in-several-tumor-types-to-be-pr-newswire-primary-pulmonary-hypertension-news-7/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Financial Results for Full Year 2007: NicOx Significantly Advances - PR Newswire  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/financial-results-for-full-year-2007-nicox-significantly-advances-pr-newswire-primary-pulmonary-hypertension-news-2/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/financial-results-for-full-year-2007-nicox-significantly-advances-pr-newswire-primary-pulmonary-hypertension-news-2/#comments</comments>
		<pubDate>Thu, 31 Jul 2008 17:31:29 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/financial-results-for-full-year-2007-nicox-significantly-advances-pr-newswire-primary-pulmonary-hypertension-news-2/</guid>
		<description><![CDATA[SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ &#8212; NicOx S.A. Euronext: COX Paris: COX today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of    Read More 
CHICAGO, July 29, 2008 – Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: [...]]]></description>
			<content:encoded><![CDATA[<p>SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ &#8212; NicOx S.A. Euronext: COX Paris: COX today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of    <a target="_blank" rel="nofollow" href='http://sev.prnewswire.com/medical-pharmaceuticals/20080303/NYM02103032008-1.html'>Read More </a></p>
<p>CHICAGO, July 29, 2008 – Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) today are presenting detailed results from the companies’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease at    <a target="_blank" rel="nofollow" href='http://www.pharmalive.com/News/index.cfm?articleid=559757'>Read More </a></p>
<p>Elan Corporation, plc ELN and Wyeth WYE today are presenting detailed results from the companies ’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer&#8217;s disease at the Alzheimer ’ s Association ’ s    <a target="_blank" rel="nofollow" href='http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=BW&#038;date=20080729&#038;id=8955771'>Read More </a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/financial-results-for-full-year-2007-nicox-significantly-advances-pr-newswire-primary-pulmonary-hypertension-news-2/feed/</wfw:commentRSS>
		</item>
		<item>
		<title>Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial - MSN MoneyCentral  (Primary Pulmonary Hypertension News)</title>
		<link>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/elan-and-wyeth-present-encouraging-results-from-phase-2-clinical-trial-msn-moneycentral-primary-pulmonary-hypertension-news/</link>
		<comments>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/elan-and-wyeth-present-encouraging-results-from-phase-2-clinical-trial-msn-moneycentral-primary-pulmonary-hypertension-news/#comments</comments>
		<pubDate>Thu, 31 Jul 2008 17:30:46 +0000</pubDate>
		<dc:creator>tedthedj</dc:creator>
		
	<category>primary pulmonary hypertension</category>
		<guid isPermaLink="false">http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/elan-and-wyeth-present-encouraging-results-from-phase-2-clinical-trial-msn-moneycentral-primary-pulmonary-hypertension-news/</guid>
		<description><![CDATA[Elan Corporation, plc ELN and Wyeth WYE today are presenting detailed results from the companies ’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer&#8217;s disease at the Alzheimer ’ s Association ’ s    Read More 
IRVINE, Calif., Feb. 20 /PRNewswire/ &#8212; LifeMasters Supported SelfCare, Inc., a [...]]]></description>
			<content:encoded><![CDATA[<p>Elan Corporation, plc ELN and Wyeth WYE today are presenting detailed results from the companies ’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer&#8217;s disease at the Alzheimer ’ s Association ’ s    <a target="_blank" rel="nofollow" href='http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=BW&#038;date=20080729&#038;id=8955771'>Read More </a></p>
<p>IRVINE, Calif., Feb. 20 /PRNewswire/ &#8212; LifeMasters Supported SelfCare, Inc., a national provider of health improvement services, announced that it has received an extension from the Centers for Medicare &#038; Medicaid Services (CMS) of its disease    <a target="_blank" rel="nofollow" href='http://sev.prnewswire.com/health-care-hospitals/20080220/LAW05120022008-1.html'>Read More </a>
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.your-news-blog.com/primary-pulmonary-hypertension/2008/07/31/elan-and-wyeth-present-encouraging-results-from-phase-2-clinical-trial-msn-moneycentral-primary-pulmonary-hypertension-news/feed/</wfw:commentRSS>
		</item>
	</channel>
</rss>
